ADVANCE POC I Risk pillar - Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: Incidence rates of safety outcomes of whole-cell pertussis and acellular pertussis vaccines in pre-school children

First published 14/06/2016

Last updated 02/07/2024

EU PAS number:

EUPAS13779

Study

Finalised

Documents

Study protocol

Initial protocol

ADVANCE POC-Risk-Protocol

English (1.84 MB - PDF)View document

Study results

ADVANCE D5 6_ExecSummaryEU-PAS

English (221.73 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Signed checklist for study protocols

ENCePPChecklistforStudyProtocols ADVANCE POC risk

English (117.04 KB - PDF)View document

Secondary tabs